Comparing two nasal pain medicines for finger numbing
Treatments studied
Part of Pain clinical trials.
This study tests two different nasal sprays to see which one makes the numbing injection for finger procedures more comfortable. It might help reduce pain during the numbing process.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You weigh more than 50 kilograms (about 110 pounds)
- You need a nerve block (numbing medicine) for a finger procedure
- You have not taken any pain medicine in the last 6 hours
- You do not have certain stomach, kidney, liver, or bleeding problems
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two strengths of a pain-relief nasal spray (ketorolac) to see which works better and is safe for adults with recent acute pain. It may offer a needle-free option for managing pain in the emergency department.
This study compares two different nasal spray pain medicines (sufentanil and ketamine) to see which works better and is safer for children with severe pain from injuries, like a broken arm or leg.
This trial looks at how well different numbing and pain-relief medicines work in children during routine care. It may help doctors choose safer, better pain control for kids who need these medicines.
This study tests a numbing injection in the cheek area before septorhinoplasty to see if it improves pain control and reduces the need for strong IV pain medicine. It may help you have a smoother recovery with less discomfort.
This trial tests if two different medicines, dexamethasone and dexmedetomidine, given as a nerve block in your nose during rhinoplasty can better control pain after surgery.
This study compares two medicines used during nasal surgery to keep blood pressure stable and reduce bleeding. One is a short-acting painkiller (remifentanil), and the other is a blood pressure-lowering drug (nicardipine). If you are having planned nasal surgery eliminated for participation, you might be eligible.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.